Literature DB >> 84732

Long survival in patients with bronchogenic carcinoma complicated by superior vena caval obstruction.

C Nogeire, F Mincer, C Botstein.   

Abstract

When superior vena caval obstruction complicates cancer of the lung; the prognosis is grave; 1 percent of such patients survive for one year. Improved palliation is reported from many radiation therapy centers using higher initial dose fractions and tumoricidal doses. We now report the findings in three patients with histologically confirmed bronchogenic carcinoma who had superior vena caval obstruction and who survived for nine years (two patients) and seven years (one patient). Aggressive therapy with irradiation seems to provide better palliation and may occasionally be associated with remarkably long survivals in this normally highly lethal disease.

Entities:  

Mesh:

Year:  1979        PMID: 84732     DOI: 10.1378/chest.75.3.325

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Prolonged survival in bronchogenic carcinoma complicated by superior vena cava obstruction.

Authors:  A Schecter; J Reichel
Journal:  Lung       Date:  1981       Impact factor: 2.584

2.  Stenting and superior vena caval syndrome.

Authors:  P Wilkinson; J MacMahon; L Johnston
Journal:  Ir J Med Sci       Date:  1995 Apr-Jun       Impact factor: 1.568

3.  Need for invasive diagnostic procedures in the management of superior vena cava syndrome.

Authors:  P P Kumar; R R Good
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798

Review 4.  Superior vena cava syndrome.

Authors:  L J Wudel; J C Nesbitt
Journal:  Curr Treat Options Oncol       Date:  2001-02

5.  Radiation-induced superior vena cava syndrome.

Authors:  Y Lee; R Doering; A Jihayel
Journal:  Tex Heart Inst J       Date:  1995

Review 6.  Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome.

Authors:  Christopher Straka; James Ying; Feng-Ming Kong; Christopher D Willey; Joseph Kaminski; D W Nathan Kim
Journal:  Springerplus       Date:  2016-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.